The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2025Developing an ELISA Immunoassay for Monitoring Phosphorylation of Proteins Associated with Parkinson’s Disease
Study Rationale: As Parkinson’s disease (PD) progresses, one of the molecular changes that occurs is an increase in the number of phosphate groups that are added to proteins. In this project, we will...
-
Research Grant, 2025Enhancing Recruitment of Individuals Traditionally Underrepresented in Parkinson’s Disease Research into the SPARX3 Clinical Trial
Study Rationale: SPARX3 is a Phase 3 clinical trial designed to assess whether high intensity aerobic exercise can delay progression of Parkinson’s disease (PD) better than does moderate intensity...
-
Research Grant, 2025Construction of a Living Library of Digital Technologies for Use in Research and Care of Parkinson’s Disease.
Study Rationale: Interest in digital technologies within Parkinson’s disease (sensors, devices, specific smartphone apps) for early detection and disease monitoring has increased in recent years. Over...
-
Research Grant, 2025Identifying Protein Changes Associated with Parkinson’s Disease: Proteomics Public Data Compilation
Study Rationale: Accumulation of toxic protein aggregates is a hallmark of neurodegenerative disorders that include Parkinson’s disease (PD), Lewy body dementia (LBD) and multiple system atrophy (MSA)...
-
Accelerating Biological Understanding and Therapeutic Translation for PD-Biomarkers, 2025Development of an Assay for Rapid Detection of Activated LRRK2
Study Rationale: Mutations associated with Parkinson’s disease (PD) elevate the activity of a protein called Leucine-rich repeat kinase 2 (LRRK2). Kinases add phosphate groups to other proteins and to...
-
Parkinson’s Disease Therapeutics Pipeline Program, 2024A Novel Brain-penetrating Antibody for Treating Parkinson’s Disease
Study Rationale: Inflammation in the brain is an important trigger of Parkinson’s disease (PD). Our strategy is to block one of the key molecules mediating inflammation and degeneration in the brain...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.